Published in J Hosp Infect on February 11, 2009
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Staphylococcus aureus oropharyngeal carriage in a prison population. Clin Infect Dis (2011) 1.28
A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother (2012) 1.02
Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in different specimens. J Clin Microbiol (2010) 0.90
Should patients with hip joint prosthesis receive antibiotic prophylaxis before dental treatment? J Oral Microbiol (2010) 0.82
Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature. Infect Drug Resist (2016) 0.81
Active surveillance of the trachea or throat for MRSA is more sensitive than nasal surveillance and a better predictor of MRSA infections among patients in intensive care. PLoS One (2014) 0.80
High prevalence of Panton-Valentine leukocidin among methicillin-sensitive Staphylococcus aureus colonization isolates in rural Iowa. Microb Drug Resist (2012) 0.77
Feasibility of rapid polymerase chain reaction for detection of methicillin-resistant Staphylococcus aureus colonization among emergency department patients with abscesses. Open Access Emerg Med (2013) 0.75
The evaluation of MRSA surveillance cultures by the number and combinations of anatomical sites. Zdr Varst (2016) 0.75
Glutamate dehydrogenase as confirmatory test for Clostridium difficile toxin A/B-positive stools. J Hosp Infect (2010) 1.68
MIC determination by the E test. J Antimicrob Chemother (1991) 1.40
Infectious osteitis pubis in an HIV seropositive female. Genitourin Med (1994) 1.40
Has the severity of Clostridium difficile infections increased? J Hosp Infect (2006) 1.38
An audit of peripheral catheter care in a teaching hospital. J Hosp Infect (1996) 1.37
Immunohistological demonstration of Salmonella virchow in a case of infant death. J Clin Pathol (1989) 1.17
Fluconazole and Candida krusei infections. J Hosp Infect (1991) 1.01
A case of norovirus and Clostridium difficile infection: casual or causal relationship? J Hosp Infect (2007) 0.91
Genomic variation in Streptococcus mutans: deletions affecting the multiple pathways of beta-glucoside metabolism. Oral Microbiol Immunol (2006) 0.87
Once-daily aminoglycoside dosing. Lancet (1993) 0.87
Quantitative liquid chromatographic-tandem mass spectrometric determination of reserpine in FVB/N mouse plasma using a "chelating" agent (disodium EDTA) for releasing protein-bound analytes during 96-well liquid-liquid extraction. J Chromatogr B Biomed Sci Appl (2000) 0.84
A four-column parallel chromatography system for isocratic or gradient LC/MS analyses. Anal Chem (2001) 0.84
Different ribotypes in community-acquired Clostridium difficile. J Hosp Infect (2008) 0.82
The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin. J Pharmacol Exp Ther (2007) 0.80
MRSA decolonization with Prontoderm compared with chlorhexidine and mupirocin. J Hosp Infect (2010) 0.77
Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol (1989) 0.75
Workload may be related to the spread of MRSA and other infections. J Hosp Infect (2000) 0.75
Gas gangrene. Br Med J (Clin Res Ed) (1988) 0.75
Living with EMRSA-1. J Hosp Infect (1990) 0.75
Pregnancy and prosthetic heart valves. Lancet (1994) 0.75
Clinical governance and orthopaedic infection rate. J Hosp Infect (1999) 0.75
[Dermatofibroma. Anatomo-clinical correlations]. Pathologica (1983) 0.75
Increase in reported Clostridium difficile cases as unintended consequence of enhanced norovirus testing. J Hosp Infect (2013) 0.75
Candidiasis in women fitted with an intrauterine contraceptive device. Br J Obstet Gynaecol (1988) 0.75
Necrotizing enterocolitis in a patient with AIDS. AIDS (1992) 0.75
Analysis of clenbuterol in human plasma using liquid chromatography/atmospheric-pressure chemical-ionization mass spectrometry. Rapid Commun Mass Spectrom (1993) 0.75